Antiseizure medication shortages and brand switching in epilepsy


While brand switching in epilepsy is not encouraged, the high prevalence of antiseizure medications shortages, particularly for generic brands, means that avoidance of brand switching is not always possible. In such cases, pharmacists have an important role in educating and counselling patients to avoid adverse patient outcomes. By Anita Moody (nee Connor) BPharm, Medical Solutions

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?